Bexxar

Active Ingredient(s): Tositumomab
FDA Approved: * June 27, 2003
Pharm Company: * CORIXA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Bexxar Overview

Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, produced in mammalian cells.[1] Combined with radioisotope iodine 131[2] it was called Iodine I 131 Tositumomab. Unlabelled tositumomab together with iodine-labelled tositumomab was called Bexxar[1] and a personalized regimen using Bexxar was approved for the treatment of relapsed or chemotherapy/rituxan-refractory Non-Hodgkin lymphoma in 2003.[...

Read more Bexxar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tositumomab

Recent Bexxar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Bexxar: (1 result)

Sorted by National Drug Code

• 0007-3260 Bexxar Kit by Glaxosmithkline LLC

Other drugs which contain Tositumomab or a similar ingredient: (1 result)

• TOSITUMOMAB